Slideshow

Parkinson Disease: 5 Updates

Author(s):

Leo Robert

Pain related to more severe motor symptoms, phosphodiesterase 10A loss seen early, novel therapy shows promise, and other recent findings are summarized here.

Related Videos
Related Content
Walid Abi-Saab, MD (Credit: uniQure)
December 12th 2024

FDA Reaches Alignment on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington Disease

Isabella Ciccone, MPH
Episode 126: Exploring the Therapeutic Potential of ATH434 in Multiple System Atrophy
October 18th 2024

Episode 126: Exploring the Therapeutic Potential of ATH434 in Multiple System Atrophy

Marco Meglio
Carole Ho, MD (Credit: Denali)
December 11th 2024

First Patient Treated in Phase 2a Trial of Investigational BIIB122 for LRRK2-Associated Parkinson Disease

Isabella Ciccone, MPH
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
July 12th 2024

Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease

Marco Meglio
System Integration: How AI Is Weaving Itself into Neurology
December 5th 2024

System Integration: How AI Is Weaving Itself into Neurology

Marco Meglio
FDA Action Update, November 2024: Approvals, Clearance, and Clinical Hold
December 5th 2024

FDA Action Update, November 2024: Approvals, Clearance, and Clinical Hold

Isabella Ciccone, MPH
© 2024 MJH Life Sciences

All rights reserved.